Who owns the ANTHROMOLECULE trademark?

The ANTHROMOLECULE trademark is owned by MONTAI THERAPEUTICS, INC..

What class is the ANTHROMOLECULE trademark registered in?

The ANTHROMOLECULE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ANTHROMOLECULE?

The USPTO serial number for ANTHROMOLECULE is 97981248.

What is the registration number for ANTHROMOLECULE?

ANTHROMOLECULE is registered under USPTO registration number 8170136.

Sealvo

Home Search: ANTHROMOLECULEANTHROMOLECULE #97981248

Back

Updated Oct 28, 2026·19 searches this week

View on USPTO TSDR Find similar marks

ANT

USPTO Trademark Record

REGISTERED

ANTHROMOLECULE

SN 97981248·Reg 8170136·Filed Apr 04, 2023

Owner MONTAI THERAPEUTICS, INC.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ANTHROMOLECULE (Serial No. 97981248), Registration No. 8170136, is a registered US trademark filed on Apr 04, 2023 by MONTAI THERAPEUTICS, INC.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 10, 2032

Mark Intelligence

ANTHROMOLECULE (Reg. #8170136) is a registered US trademark that has been protecting its owner, MONTAI THERAPEUTICS, INC., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 04, 2023

SERIAL

97981248

REG#

8170136

REGISTERED

Mar 10, 2026

Filing Information

StatusREGISTERED

Filing DateApr 04, 2023

Serial Number97981248

Registration No.8170136

Registration DateMar 10, 2026

Status DateMar 10, 2026

Published for OppositionDec 24, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1760554

480Sep 28, 2023

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 31, 2024

First use in commerce: Oct 31, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

REGISTERED-PRINCIPAL REGISTER

Mar 10, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 10, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

DIVISIONAL PROCESSING COMPLETE

Feb 14, 2026

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Feb 14, 2026

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 14, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 14, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 13, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

DIVISIONAL REQUEST RECEIVED

Aug 14, 2025

DIVISIONAL REQUEST RECEIVED

TEAS STATEMENT OF USE RECEIVED

Aug 14, 2025

TEAS STATEMENT OF USE RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Aug 14, 2025

TEAS REQUEST TO DIVIDE RECEIVED

USE AMENDMENT FILED

Aug 14, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 18, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 24, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 24, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 18, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 25, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 25, 2024

ASSIGNED TO EXAMINER

Sep 29, 2024

ASSIGNED TO EXAMINER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 17, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 17, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 17, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 08, 2024

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Mar 25, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Mar 25, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Dec 31, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 31, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 31, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 30, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 27, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 07, 2023

NEW APPLICATION ENTERED

Other Marks by MONTAI THERAPEUTICS, INC.

Additional USPTO filings from the same owner.

CON

CONECTA

98466226

MONTAI THERAPEUTICS, INC.

REGISTERED

MON

MONTAI

90271751

MONTAI THERAPEUTICS, INC.

REGISTERED

ANT

ANTHROLOG

98662116

Montai Therapeutics, Inc.

PENDING

ANT

ANTHROMOLECULE

97871746

MONTAI THERAPEUTICS, INC.

ABANDONED

Other Marks by Christina M. Licursi

Additional USPTO filings handled by the same attorney of record.

MAX

MAXYIELD

99164353

REGISTERED

SPR

SPROUTCHANGE

98716496

REGISTERED

UNI

UNIFIRST U1ST

88432196

REGISTERED

THR

THREE POSTS

88825997

REGISTERED

ANTHROMOLECULE

Run a conflict check

Other Marks by MONTAI THERAPEUTICS, INC.

Other Marks by Christina M. Licursi

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company